• 出版社/出版日：Mordor Intelligence / 2018年3月
|Single User（1名様用）||￥459,000 (USD4,250)||▷ お問い合わせ|
|Team User（7名様用）||￥486,000 (USD4,500)||▷ お問い合わせ|
|Corporate User||￥945,000 (USD8,750)||▷ お問い合わせ|
The global fluid management systems market is estimated to witness a high CAGR during the forecast period. Fluid management is an important part of every diagnostic and interventional angiographic procedure.
Rise in the Number of Minimally Invasive Surgery Procedures
Technological advancements in surgeries have made them easier and more efficient. Laparoscopy procedures have become more popular in recent times. This procedure took a long time to be widely accepted as a gold standard in this market. However, with the increasing success of laparoscopy over the past decade, there has been an increasing preference for surgical procedures to be less-invasive. It is now considered as a safe procedure for treating obesity as well. New minimally invasive surgery procedures have been developed and adapted into treatment modalities for various surgeries. Hence, these increasing minimally invasive surgery procedures are driving the fluid management systems market. Other factors, such as increase in funds across the globe for endosurgical procedures, rising incidences of digestive, respiratory, neural & reproductive system related diseases, and favorable reimbursement policies are boosting the market.
Lack of Skilled Labor/Surgeons
Fluid management plays an integral part in the overall surgical therapy. Proper administration of fluids is critical, especially in patients who undergo major surgeries, such as emergency laparotomies, bowel resections, and hepatectomy procedures. Therefore, surgeons must be aware of the pros and cons of current fluid management strategies and their effects on surgical outcome. Lack of skilled surgeons is one of the main restraints in this market. Many developed and underdeveloped countries lack the essential infrastructure to meet this issue. A classic example is Africa, where skilled surgeons are extremely low in number due to lack of training programs. Africa has a huge deficiency in the number of healthcare workers; one surgeon for every 2.5 million Africans in rural areas; 10 fully trained surgeons for a population of 6 million in Sierra Leone. Malawi has 21 district hospitals, without a single permanent surgeon. The lack of skilled labor and expensive surgical procedures are restraining the market growth of fluid management systems.
US has the Highest Market Share
In North America, the United States is dominating the fluid management systems market due to the advancement in technology, increasing aging and ill population, rising number of minimally invasive surgeries, and growth in the number of dialysis centers. Asia-Pacific is expected to record substantial growth during the forecast period.
Key Developments in the Market
• December 2017: Roche and Ignyta made a definitive merger agreement.
• July 2017: Baxter had acquired the Claris Injectables.
Major Players: ACACIA, INC., ALCOR SCIENTIFIC, INC., B BRAUN MELSUNGEN AG, CAREFUSION CORPORATION, ANIMAS CORPORATION, BAXTER HEALTHCARE CORPORATION, MEDTRONIC, ROCHE, and STRYKER INSTRUMENTS, amongst others.
Reasons to Purchase this Report
• Current and future fluid management systems market outlook in the developed and emerging markets.
• Analyzing various perspectives of the market with the help of Porter’s five forces analysis.
• The segment that is expected to dominate the market.
• Regions that are expected to witness the fastest growth during the forecast period.
• Identify the latest developments, market shares, and strategies employed by the major market players.
• 3-month analyst support, along with the Market Estimate sheet (in excel).
Customization of the Report
• This report can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.レポート目次
1.1 Market Definition
2. Research Methodology
3. Executive Summary
4. Key Inferences
5. Market Overview
5.1 Current Market Scenario
5.2 Porter’s Five Forces Analysis
5.2.1 Bargaining Power of Suppliers
5.2.2 Bargaining Power of Consumers
5.2.3 Threat of New Entrants
5.2.4 Threat of Substitute Product and Services
5.2.5 Competitive Rivalry within the Industry
6. Drivers, Restraints, Opportunities and Challenges Analysis (DROC)
6.1 Market Drivers
6.1.1 Increase in Funds across the Globe for Endosurgical Procedures
6.1.2 Rise in the Number of Minimally Invasive Surgery Procedures
6.1.3 Rising Incidences of Digestive, Respiratory, Neural & Reproductive System Related Diseases
6.1.4 Favorable Reimbursement Policies Boosting the Market Growth
6.2 Market Restraints
6.2.1 Lack of Skilled Labor/Surgeons
6.2.2 Expensive Surgical Procedures
6.4 Key Challenges
7. Market Segmentation
7.1 By Products
188.8.131.52 Contrast Injection Equipment
184.108.40.206 Vacuum Equipment
220.127.116.11 Pressure Monitoring
18.104.22.168 Fluid Warming
22.214.171.124 Waste Management
7.2 By Disposables and Accessories
7.2.1 Visualization Systems
126.96.36.199 Endoscopic Cameras
188.8.131.52.1 SD Visualization equipment
184.108.40.206.2 HD Visualization equipment
220.127.116.11 Other Visualization Accessories
7.2.2 Fluid Administration Sets
7.2.6 Waste Disposal Equipment
7.2.8 Tubing Sets
18.104.22.168 High Pressure Tubing
22.214.171.124 Pressure Monitoring Tubing
7.3 By Application
7.4 By Geography
7.4.1 North America
126.96.36.199 United States
188.8.131.52 United Kingdom
184.108.40.206 Rest of Europe
220.127.116.11 Australia & New Zealand
18.104.22.168 South Korea
22.214.171.124 Rest of Asia-Pacific
7.4.4 Middle East & Africa
126.96.36.199 South Africa
188.8.131.52 Rest of the Middle East & Africa
7.4.5 South America
184.108.40.206 Rest of South America
8. Competitive Landscape
8.1 Mergers & Acquisition Analysis
8.2 Agreements, Collaborations, and Partnerships
8.3 New Products Launches
9. Key Players
9.1 Acacia, Inc.
9.2 ALCOR Scientific, Inc.
9.3 B Braun Melsungen AG
9.4 Carefusion Corporation
9.5 Animas Corporation
9.6 Baxter Healthcare Corporation
9.7 Medtronic Plc
9.8 F. Hoffmann-La Roche AG
9.9 Stryker Corporation
10. Future of the Market